VistaSeq® RET Comprehensive Analysis

Alphabetical Test listing

VistaSeq® RET Comprehensive Analysis-994

  
VistaSeq® RET Comprehensive Analysis
  
994
  
LAB994
  
MSO
  
Familial Cancer testing
Hereditary Cancer testing
Inherited Cancer testing
Medullary Thyroid Cancer (MTC)
MEN2
Multiple Endocrine Neoplasia, type 2
Parathyroid
Pheochromocytoma
  
RET Gene
  

This assay is intended for patients with a history consistent with Multiple Endocrine Neoplasia, type 2

  
Whole blood
  
  
10 mL
  
7 mL
  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  

Lavender (EDTA), 10mL

  

Yellow ACD (A or B)

 

  

Immediately following collection, mix by inverting 8 - 10 times to prevent clotting

  

Yellow ACD (A or B)

  

A hereditary cancer clinical questionnaire should be submitted with all specimens

  

Ambient (preferred) - 60 days

Refrigerated - 60 days

  
LabCorp (483472); R-NX
  
20 - 28 days
  
81406; 81479
  
03/18/2024
  
03/18/2024